from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2069/sigC

LFCtreatmentdescriptionclass of inhibitor

0.583

Amikacinug/mL Amikacintranslation

0.944

Cap5-10ug/mL Capreomycintranslation

2.199

Rox10-50 ug/mL Roxithromycintranslation

0.347

SM2-5 ug/mL Streptomycintranslation

0.941

Tet5-10 ug/mL Tetracyclinetranslation

-0.389

Rif0.2-5ug/mL Rifampicintranscription

0.305

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.270

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.497

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.858

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.718

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.042

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.456

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.752

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.749

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.160

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.378

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.637

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.321

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.893

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.952

KCN5-20 ug/mL Potassium cyaniderespiration

-0.504

NaN30.2-2 mM Sodium aziderespiration

0.716

Nigericin50 uM Nigericinrespiration

-0.547

TRC10-150 ug/mL Triclosanrespiration

-2.060

TRZ10-25 ug/mL Thioridazinerespiration

-1.773

Valinomycin0.5-10 uM Valinomycinrespiration

0.795

ZnSO42 mM ZnSO4respiration

-0.604

menadione6-10 ug/mL Menadionerespiration

0.360

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.366

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.632

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.732

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.346

NRP_1Non-replicating persistence stage 1dosRassociated

0.695

Amp0.2mg/mL AmpicillincellWall

0.354

Cephalexin20-100 ug/mL CephalexincellWall

0.593

Cerulenin0.32-5 ug/mL CerulenincellWall

0.608

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.725

EMB10-20 ug/mL EthambutolcellWall

0.922

Eta12-40 ug/mL EthionamidecellWall

0.692

INH0.2-0.4 ug/mL IsoniazidcellWall

0.872

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.574

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.853

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.295

BZA0.12 mg/mL BenzamidearomaticAmides

0.135

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.261

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.006

H2O24 mM hydrogen peroxideDNAdamaging

0.583

Levo10 ug/mL LevofloxacinDNAdamaging

0.556

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.208

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.065

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.411

UVUV-irradiationDNAdamaging

-1.545

ARP41-4 ug/mL Antitubercular compound ARP4?

0.439

Antimycin12.5-50 ug/mL Antimycin A?

0.110

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.424

PA_110-50 ug/mL Antitubercular compound PA-1?

0.564

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.242

PA8240.2-2 ug/mL PA-824?

-0.740

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.134

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.055

Verapamil50 uM Verapamil?

0.613

mercaptoethanol2 mM 2-Mercaptoethanol?

0.570

methoxatin10-20 ug/mL Methoxatin?